Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_assertion description "[After stimulation with TLR2 and TLR4 agonists, AVICs express higher levels of pro-inflammatory and pro-osteogenic mediators (bone morphogenetic protein [BMP]-2, runt-related transcription factor 2) and greater osteogenic phenotypic changes (alkaline phosphatase [ALP] activity, calcified nodule formation) than PVICs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_assertion evidence source_evidence_literature NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_assertion SIO_000772 19195606 NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_assertion wasDerivedFrom befree-2016 NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_assertion wasGeneratedBy ECO_0000203 NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.
- befree-2016 importedOn "2016-02-19" NP718821.RAgCdSeal0BAq6j5pd8P7oIzExq_wcIQEKmktpbVAnd1c130_provenance.